Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
AbbVie
Scientific Title
A Phase 1 First In Human Study Evaluating Safety And Efficacy Of ABBV-637 As Either Monotherapy Or In Combination In Adult Subjects With Relapsed And Refractory Solid Tumors